Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

UROGEN PHARMA LTD.

(URGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on UROGEN PHARMA LTD.
Target Price consensus revisions : last 18 months
Recommendations (Chart) UROGEN PHARMA LTD.
Analyst Recommendations on UROGEN PHARMA LTD.
01/18HC Wainwright Adjusts UroGen Pharma's Price Target to $34 From $50, Reiterates Buy Rating
MT
2021UROGEN PHARMA : Goldman Sachs Adjusts Price Target for UroGen Pharma to $27 From $26, Maintains Neutral Ra..
MT
2021UROGEN PHARMA : Oppenheimer Adjusts UroGen Pharma's Price Target to $30 From $34, Maintains Outperform Rat..
MT
2021UROGEN PHARMA : HC Wainwright Adjusts Price Target on UroGen Pharma to $50 From $57, Maintains Buy Rating
MT
2021UROGEN PHARMA : Oppenheimer Adjusts UroGen Pharma PT to $34 From $40, Maintains Outperform Rating
MT
2021UROGEN PHARMA : Stifel Adjusts UroGen Pharma's Price Target to $32 from $46, Keeps Buy Rating
MT
2020UROGEN PHARMA : Oppenheimer Adjusts UroGen Pharma PT to $40 From $48, Maintains Outperform Rating
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 8,01 $
Average target price 36,60 $
Spread / Average Target 357%
High Price Target 51,00 $
Spread / Highest target 537%
Low Price Target 23,00 $
Spread / Lowest Target 187%
Consensus detail
Consensus revision (last 18 months)